CARDIOME PHARMA CORP - COM NO PAR (CRME)

CUSIP: 14159U301

Q4 2015 13F Holders as of 31 Dec 2015

Type / Class
Equity / COM NO PAR
Total 13F shares
12,609,240
Share change
+215,394
Total reported value
$102,259,000
Price per share
$8.11
Number of holders
28
Value change
+$1,568,385
Number of buys
16
Number of sells
10

Quarterly Holders Quick Answers

What is CUSIP 14159U301?
CUSIP 14159U301 identifies CRME - CARDIOME PHARMA CORP - COM NO PAR in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CARDIOME PHARMA CORP - COM NO PAR (CRME) as of Q4 2015

As of 31 Dec 2015, CARDIOME PHARMA CORP - COM NO PAR (CRME) was held by 28 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 12,609,240 shares. The largest 10 holders included WESTFIELD CAPITAL MANAGEMENT CO LP, PUTNAM INVESTMENTS LLC, Clough Capital Partners L P, Rock Springs Capital Management LP, TURNER INVESTMENTS, L.P., FMR LLC, PointState Capital LP, AlphaOne Investment Services, LLC, ACUTA CAPITAL PARTNERS, LLC, and MACKENZIE FINANCIAL CORP. This page lists 28 institutional shareholders reporting positions in this security for the Q4 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.